# Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects

> **NCT03027336** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria di Parma** · enrollment: 39 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DIETARY_SUPPLEMENT:** Coleosoma
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03027336
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Parma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-10
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03027336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03027336, "Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03027336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*